CELL THERAPEUTICS INC

Inactive Instrument

Analyst Reco. Cell Therapeutics Inc Nasdaq

Equities

US1509346029

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2023	DRI Healthcare Trust Receives US$54.8 Million in Debt Repayment	MT
2023	DRI Healthcare Trust Brief: Announcing US$54.8 Million Debt Repayment from CTI BioPharma Corp.	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

SVB Securities Downgrades CTI BioPharma to Market Perform From Outperform, Adjusts Price Target to $9.10 From $13	23-05-16	MT
JMP Securities Downgrades CTI BioPharma to Market Perform From Market Outperform	23-05-11	MT
Needham Downgrades CTI BioPharma to Hold From Buy With $9 Price Target	23-05-11	MT
European shares edge higher as US CPI data looms, Credit Agricole gains	23-05-10	RE
TD Cowen Adjusts Price Target on CTI BioPharma to $8 From $10, Maintains Outperform Rating	23-04-17	MT
SVB Securities Starts CTI BioPharma at Outperform with $13 Price Target	22-10-17	MT
Jefferies Starts CTI BioPharma at Buy With $13 Price Target	22-09-01	MT
JMP Securities Adjusts CTI BioPharma Price Target to $9 From $6, Maintains Market Outperform Rating	22-08-09	MT
Cowen Starts CTI BioPharma at Outperform With $10 Price Target	22-07-07	MT
Needham Raises CTI BioPharma's Price Target to $8 From $5, Maintains Buy Rating	22-03-02	MT
JMP Securities Adjusts CTI BioPharma Price Target to $5 From $4, Maintains Market Outperform Rating	22-03-02	MT
Needham Adjusts Price Target on CTI BioPharma to $5 From $6, Maintains Buy Rating	21-12-01	MT
CTI BIOPHARMA : BTIG Starts CTI BioPharma at Buy With $7 Price Target	21-08-09	MT
CTI BIOPHARMA : Lake Street Adjusts Price Target on CTI BioPharma to $15 From $13, Maintains Buy Rating	21-06-01	MT
CTI BIOPHARMA : Stifel Initiates CTI BioPharma at Buy Rating With $5.50 Price Target	21-05-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer